MedPath

Kit for the Preparation of Technetium Tc99m Mertiatide

Kit for the Preparation of Technetium Tc 99m Mertiatide

Approved
Approval ID

0ad62039-f848-4f3d-b489-2524e6b6b86e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 22, 2021

Manufacturers
FDA

Sun Pharmaceutical Industries, Inc.

DUNS: 139261648

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betiatide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code45567-0655
Application NumberANDA208994
Product Classification
M
Marketing Category
C73584
G
Generic Name
Betiatide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2021
FDA Product Classification

INGREDIENTS (7)

Stannous ChlorideInactive
Quantity: 0.05 mg in 1 1
Code: 1BQV3749L5
Classification: IACT
BetiatideActive
Quantity: 1 mg in 1 1
Code: 9NV2SR34P8
Classification: ACTIB
Lactose MonohydrateInactive
Quantity: 20 mg in 1 1
Code: EWQ57Q8I5X
Classification: IACT
Stannous Chloride AnhydrousInactive
Quantity: 0.2 mg in 1 1
Code: R30H55TN67
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
Sodium TartrateInactive
Quantity: 40 mg in 1 1
Code: QTO9JB4MDD
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Kit for the Preparation of Technetium Tc99m Mertiatide - FDA Drug Approval Details